MX9705411A - Procedimiento de dosificacion ultrasensible de la troponina 1 cardiaca. - Google Patents

Procedimiento de dosificacion ultrasensible de la troponina 1 cardiaca.

Info

Publication number
MX9705411A
MX9705411A MX9705411A MX9705411A MX9705411A MX 9705411 A MX9705411 A MX 9705411A MX 9705411 A MX9705411 A MX 9705411A MX 9705411 A MX9705411 A MX 9705411A MX 9705411 A MX9705411 A MX 9705411A
Authority
MX
Mexico
Prior art keywords
ultrasensitive
troponine
assaying
assaying cardiac
cardiac troponine
Prior art date
Application number
MX9705411A
Other languages
English (en)
Other versions
MXPA97005411A (es
Inventor
Charles Calzolari
Odile Flecheux
Bernard Pau
Original Assignee
Pasteur Sanofi Diagnostics
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pasteur Sanofi Diagnostics filed Critical Pasteur Sanofi Diagnostics
Publication of MX9705411A publication Critical patent/MX9705411A/es
Publication of MXPA97005411A publication Critical patent/MXPA97005411A/es

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6887—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids from muscle, cartilage or connective tissue
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/577—Immunoassay; Biospecific binding assay; Materials therefor involving monoclonal antibodies binding reaction mechanisms characterised by the use of monoclonal antibodies; monoclonal antibodies per se are classified with their corresponding antigens
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/32—Cardiovascular disorders
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/32—Cardiovascular disorders
    • G01N2800/324—Coronary artery diseases, e.g. angina pectoris, myocardial infarction

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Analytical Chemistry (AREA)
  • Pathology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
  • External Artificial Organs (AREA)
  • Measuring Pulse, Heart Rate, Blood Pressure Or Blood Flow (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
  • Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
  • Steroid Compounds (AREA)

Abstract

La presente invencion se refiere a un procedimiento de dosificacion ultrasensible de la troponina I cardiaca, efectuado por quimioluminiscencia.
MXPA/A/1997/005411A 1995-01-19 1997-07-17 Procedimiento de dosificacion ultrasensible de la troponina i cardiaca MXPA97005411A (es)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
FR9500597 1995-01-19
FR95/00597 1995-01-19
FR9500597A FR2729759A1 (fr) 1995-01-19 1995-01-19 Procede de dosage ultrasensible de la troponine i cardiaque
PCT/FR1996/000095 WO1996022535A1 (fr) 1995-01-19 1996-01-19 Procede de dosage ultrasensible de la troponine i cardiaque

Publications (2)

Publication Number Publication Date
MX9705411A true MX9705411A (es) 1997-11-29
MXPA97005411A MXPA97005411A (es) 1998-07-03

Family

ID=

Also Published As

Publication number Publication date
JPH10512672A (ja) 1998-12-02
GR3030113T3 (en) 1999-07-30
CN1105306C (zh) 2003-04-09
ES2131929T3 (es) 1999-08-01
EP0804736B1 (fr) 1999-03-31
EP0804736A1 (fr) 1997-11-05
AU703944B2 (en) 1999-04-01
FR2729759A1 (fr) 1996-07-26
DE69601922D1 (de) 1999-05-06
ATE178410T1 (de) 1999-04-15
BR9607164A (pt) 1997-11-11
DE69601922T2 (de) 1999-10-07
JP3558643B2 (ja) 2004-08-25
WO1996022535A1 (fr) 1996-07-25
AU4625196A (en) 1996-08-07
CN1176002A (zh) 1998-03-11
DK0804736T3 (da) 1999-10-18
KR100237239B1 (ko) 2000-01-15
KR19980701608A (ko) 1998-06-25

Similar Documents

Publication Publication Date Title
GR3030113T3 (en) Ultrasensitive process for assaying cardiac troponine i
ZA955466B (en) Stereochemical wortmannin derivatives
UA5972A1 (uk) Спосіб отримання заміщених 2-меркапто-імідазолів
BG101569A (en) Method for sildenaphil preparation
GB9822376D0 (en) Stabilizer compounds
FI971609A (fi) Menetelmä 4a,5,9,10,11,12-heksahydro-6H-bentsofuro-(3a,3,2-ef)(2)-bentsatsepiinijohdannaisten valmistamiseksi
MX9605206A (es) 1alfa,26-dihidroxi-d-homo-vitamina d3.
UA6044A1 (uk) Спосіб одержання метіленових похідних андроста-1,4 -діен-3,17-діона
HUP9900897A3 (en) Process for the production of cesium compounds
MX9705726A (es) Amidas del acido alcoximinoacetico.
ES8207584A1 (es) Procedimiento para el desdoblamiento enzimatico de acido d, l-2-amino-4-metilfosfinobutirico.
DK321884A (da) Substituerede 2-(monoannellerede (3,4-, 4,5- og 5,6-) pyridylalkylensulfinyl)-benzimidazoler
ES2124990T3 (es) Conversion de bisnoralcohol en bisnoraldehido.
MX9706744A (es) Proceso novedosos para preparar derivados de 2,3-dihidro-benzofuranol.
MY118813A (en) Compounds and method for preparing substituted 4-phenyl-4-cyanocyclohexanoic acids
DE3162065D1 (en) Process for making ductile laminates
MY110202A (en) A process for preparing 1-alkylaryl-2-alkyl-5-formylimidazoles
MX9603087A (es) Procedimiento para la obtencion de aminocarboniltriazolinonas substituidas.
MX9603450A (es) Procedimiento para la obtencion de aminotriazolinas substituidas.
GB9602866D0 (en) Novel process
EA199800040A1 (ru) СПОСОБ СИНТЕЗА БЕНЗО/b/ТИОФЕНОВ
ES8400401A1 (es) "un procedimiento para preparar un 1,4-dialcohilo inferior-3-alcoxicarbonilo inferior-pirrol-2-acetato de alcohilo inferior".
CA2210166A1 (fr) Procede de dosage ultrasensible de la troponine i cardiaque
EP0599658A3 (en) Process for the preparation of 6-beta, 14-alpha-dihydroxy-4-androstene-3,17-dione.
BG102563A (en) Method and intermediate compounds for the production of pesticidal fluorolefinic compounds

Legal Events

Date Code Title Description
FG Grant or registration
HC Change of company name or juridical status

Owner name: MACGREGOR NORWAY AS

MM Annulment or lapse due to non-payment of fees